结直肠癌肺转移灶的肺切除术:影响预后的因素。二十年经验。
Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience.
作者信息
Rena Ottavio, Casadio Caterina, Viano Franco, Cristofori Riccardo, Ruffini Enrico, Filosso Pier Luigi, Maggi Giuliano
机构信息
Department of General Thoracic Surgery, University of Torino, Ospedale San Giovanni Battista, v. Genova 3, 10126, Turin, Italy.
出版信息
Eur J Cardiothorac Surg. 2002 May;21(5):906-12. doi: 10.1016/s1010-7940(02)00088-x.
OBJECTIVE
We reviewed our experience in the surgical management of 80 patients with colorectal pulmonary metastases and investigated factors affecting survival.
MATERIAL AND METHODS
From January 1980 to December 2000, 80 patients, 43 women and 37 men with median age 63 years (range 38-79 years) underwent 98 open surgical procedure (96 muscle-sparing thoracotomy, one clamshell and one median sternotomy) for pulmonary metastases from colorectal cancer (three pneumonectomy, 17 lobectomy, seven lobectomy plus wedge resection, six segmentectomy, three segmentectomy plus wedge resection and 62 wedge resection). Pulmonary metastases were identified at a median interval of 37.5 months (range 0-167) from primary colorectal resection. Second and third resections for recurrent metastases were done in seven and in four patients, respectively.
RESULTS
Operative mortality rate was 2%. Overall, 5-year survival was 41.1%. Five-year survival was 43.6% for patients submitted to single metastasectomy and 34% for those submitted to multiple ones. Five-year survival was 55% for patients with disease-free interval (DFI) of 36 months or more, 38% for those with DFI of 0-11 months and 22.6% for those with DFI of 12-35 months (P=0.04). Five-year survival was 58.2% for patients with normal preoperative carcino-embryonic antigen (CEA) levels and 0% for those with pathologic ones (P=0.0001). Patients submitted to second-stage operation for recurrent local disease had 5-year survival rate of 50 vs. 41.1% of those submitted to single resection (P=0.326).
CONCLUSIONS
Pulmonary resection for metastases from colorectal cancer may help survival in selected patients. Single metastasis, DFI>36 months, normal preoperative CEA levels are important prognostic factors. When feasible, re-operation is a safe procedure with satisfactory long-term results.
目的
我们回顾了80例结直肠癌肺转移患者的外科治疗经验,并研究了影响生存的因素。
材料与方法
1980年1月至2000年12月,80例患者(43例女性,37例男性,中位年龄63岁,范围38 - 79岁)接受了98次开放性手术(96例保留肌肉的开胸手术、1例蛤壳式手术和1例正中胸骨切开术),用于治疗结直肠癌肺转移(3例全肺切除术、17例肺叶切除术、7例肺叶切除术加楔形切除术、6例肺段切除术、3例肺段切除术加楔形切除术和62例楔形切除术)。肺转移灶在初次结直肠癌切除术后的中位间隔时间为37.5个月(范围0 - 167个月)被发现。分别有7例和4例患者因复发性转移接受了二次和三次手术。
结果
手术死亡率为2%。总体而言,5年生存率为41.1%。接受单发性转移灶切除术的患者5年生存率为43.6%,接受多发性转移灶切除术的患者为34%。无病间期(DFI)≥36个月的患者5年生存率为55%,DFI为0 - 11个月的患者为38%,DFI为12 - 35个月的患者为22.6%(P = 0.04)。术前癌胚抗原(CEA)水平正常的患者5年生存率为58.2%,病理水平异常的患者为0%(P = 0.0001)。因局部复发性疾病接受二期手术的患者5年生存率为50%,而接受单次切除术的患者为41.1%(P = 0.326)。
结论
结直肠癌肺转移灶的肺切除术可能有助于部分患者生存。单发性转移、DFI>36个月、术前CEA水平正常是重要的预后因素。在可行的情况下,再次手术是一种安全的手术,长期效果良好。